- Gu S, Wang X, Qiao Q, Gao W, Wang J, Dong H. Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China. Diabetes, obesity & metabolism. 2017;19(12):1688-97.
- Lasalvia P, Baquero L, Otalora-Esteban M, Castaneda-Cardona C, Rosselli D. Cost Effectiveness of Dulaglutide Compared with Liraglutide and Glargine in Type 2 Diabetes Mellitus Patients in Colombia. Value in health regional issues. 2017;14:35-40.
- Loganathan T, Ng CW, Lee WS, Hutubessy RCW, Verguet S, Jit M. Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia. Health policy and planning. 2017.
HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.
Wednesday 17 January 2018
December’s CEAs, systematic reviews and epidemiological models in LMICs
To help us keep on top of current research in low and middle-income countries, we are running a monthly search of research that is aligned to our core research interests. It's a simple search strategy, with those published last month that are most aligned to our interests listed below. The full list of articles is kept in our "Searches archive" in the right-hand column.